This study aims to analyze the factors that influence the progression-free survival time of PCa patients after endocrine therapy in an attempt to improve the prognosis of the disease.
2
日前，约翰·霍普金斯的研究者发现在内分泌治疗无反应的患者的前列腺癌细胞的激素受体存在明显的差异。
Now, researchers at Johns Hopkins have discovered critical differences in the hormone receptors on prostate cancer cells in patients who no longer respond to this therapy.
3
目的分析调强适形放射治疗(IMRT)联合内分泌治疗对中晚期前列腺癌的治疗效果。
Objective To evaluate the therapeutic effects of intensity modulated radiation therapy (IMRT) in combination with hormonotherapy in the treatment of intermediate and advanced prostate carcinoma.
点击反馈